28207880|t|Skeletal muscle metabolic adaptations to endurance exercise training are attainable in mice with simvastatin treatment
28207880|a|We tested the hypothesis that a 6-week regimen of simvastatin would attenuate skeletal muscle adaptation to low-intensity exercise. Male C57BL/6J wildtype mice were subjected to 6-weeks of voluntary wheel running or normal cage activities with or without simvastatin treatment (20 mg/kg/d, n = 7-8 per group). Adaptations in in vivo fatigue resistance were determined by a treadmill running test, and by ankle plantarflexor contractile assessment. The tibialis anterior, gastrocnemius, and plantaris muscles were evaluated for exercised -induced mitochondrial adaptations (i.e., biogenesis, function, autophagy). There was no difference in weekly wheel running distance between control and simvastatin - treated mice (P = 0.51). Trained mice had greater treadmill running distance (296%, P<0.001), and ankle plantarflexor contractile fatigue resistance (9%, P<0.05) compared to sedentary mice, independent of simvastatin treatment. At the cellular level, trained mice had greater mitochondrial biogenesis (e.g., ~2-fold greater PGC1α expression, P<0.05) and mitochondrial content (e.g., 25% greater citrate synthase activity, P<0.05), independent of simvastatin treatment. Mitochondrial autophagy -related protein contents were greater in trained mice (e.g., 40% greater Bnip3, P<0.05), independent of simvastatin treatment. However, Drp1, a marker of mitochondrial fission, was less in simvastatin treated mice, independent of exercise training, and there was a significant interaction between training and statin treatment (P<0.022) for LC3-II protein content, a marker of autophagy flux. These data indicate that whole body and skeletal muscle adaptations to endurance exercise training are attainable with simvastatin treatment, but simvastatin may have side effects on muscle mitochondrial maintenance via autophagy, which could have long-term implications on muscle health.
28207880	0	15	Skeletal muscle	T017	UMLS:C0242692
28207880	26	37	adaptations	T038	UMLS:C0392673
28207880	87	91	mice	T204	UMLS:C0025929
28207880	97	108	simvastatin	T103	UMLS:C0074554
28207880	109	118	treatment	T058	UMLS:C0087111
28207880	158	165	regimen	T058	UMLS:C0040808
28207880	169	180	simvastatin	T103	UMLS:C0074554
28207880	197	212	skeletal muscle	T017	UMLS:C0242692
28207880	213	223	adaptation	T038	UMLS:C0392673
28207880	256	278	C57BL/6J wildtype mice	T204	UMLS:C0025929
28207880	374	385	simvastatin	T103	UMLS:C0074554
28207880	386	395	treatment	T058	UMLS:C0087111
28207880	429	440	Adaptations	T038	UMLS:C0392673
28207880	452	459	fatigue	T033	UMLS:C0015672
28207880	492	514	treadmill running test	T058	UMLS:C0087110
28207880	523	542	ankle plantarflexor	T017	UMLS:C0581542
28207880	543	554	contractile	T038	UMLS:C0026820
28207880	571	588	tibialis anterior	T017	UMLS:C0242690
28207880	590	603	gastrocnemius	T017	UMLS:C0242691
28207880	609	626	plantaris muscles	T017	UMLS:C0242693
28207880	632	641	evaluated	T058	UMLS:C0220825
28207880	665	678	mitochondrial	T017	UMLS:C0026237
28207880	679	690	adaptations	T038	UMLS:C0392673
28207880	720	729	autophagy	T038	UMLS:C0004391
28207880	809	820	simvastatin	T103	UMLS:C0074554
28207880	831	835	mice	T204	UMLS:C0025929
28207880	856	860	mice	T204	UMLS:C0025929
28207880	921	940	ankle plantarflexor	T017	UMLS:C0581542
28207880	941	952	contractile	T038	UMLS:C0026820
28207880	953	960	fatigue	T033	UMLS:C0015672
28207880	1007	1011	mice	T204	UMLS:C0025929
28207880	1028	1039	simvastatin	T103	UMLS:C0074554
28207880	1040	1049	treatment	T058	UMLS:C0087111
28207880	1058	1072	cellular level	T017	UMLS:C0007634
28207880	1082	1086	mice	T204	UMLS:C0025929
28207880	1099	1123	mitochondrial biogenesis	T038	UMLS:C3494456
28207880	1147	1152	PGC1α	T103	UMLS:C1570275
28207880	1153	1163	expression	T038	UMLS:C1171362
28207880	1177	1190	mitochondrial	T017	UMLS:C0026237
28207880	1218	1234	citrate synthase	T103	UMLS:C0008855
28207880	1235	1243	activity	T038	UMLS:C0243102
28207880	1269	1280	simvastatin	T103	UMLS:C0074554
28207880	1281	1290	treatment	T058	UMLS:C0087111
28207880	1292	1305	Mitochondrial	T017	UMLS:C0026237
28207880	1306	1315	autophagy	T038	UMLS:C0004391
28207880	1325	1332	protein	T103	UMLS:C0033684
28207880	1366	1370	mice	T204	UMLS:C0025929
28207880	1390	1395	Bnip3	T103	UMLS:C1699488
28207880	1421	1432	simvastatin	T103	UMLS:C0074554
28207880	1433	1442	treatment	T058	UMLS:C0087111
28207880	1453	1457	Drp1	T103	UMLS:C1957127
28207880	1461	1467	marker	T201	UMLS:C0005516
28207880	1471	1492	mitochondrial fission	T038	UMLS:C0230871
28207880	1506	1517	simvastatin	T103	UMLS:C0074554
28207880	1526	1530	mice	T204	UMLS:C0025929
28207880	1634	1643	treatment	T058	UMLS:C0087111
28207880	1658	1672	LC3-II protein	T103	UMLS:C3711208
28207880	1684	1690	marker	T201	UMLS:C0005516
28207880	1694	1703	autophagy	T038	UMLS:C0004391
28207880	1735	1745	whole body	T017	UMLS:C0444584
28207880	1750	1765	skeletal muscle	T017	UMLS:C0242692
28207880	1766	1777	adaptations	T038	UMLS:C0392673
28207880	1829	1840	simvastatin	T103	UMLS:C0074554
28207880	1841	1850	treatment	T058	UMLS:C0087111
28207880	1856	1867	simvastatin	T103	UMLS:C0074554
28207880	1877	1889	side effects	T038	UMLS:C0879626
28207880	1893	1899	muscle	T017	UMLS:C0026845
28207880	1900	1913	mitochondrial	T017	UMLS:C0026237
28207880	1930	1939	autophagy	T038	UMLS:C0004391
28207880	1984	1990	muscle	T017	UMLS:C0026845